Chao Han , Shijun Xiang , Renchao Zhang , Gang Cen, Yuan Fang, Zhengjun Qiu, Chen Huang
{"title":"Initial experience of single-incision robotic surgery for distal gastrectomy with da Vinci Xi platform","authors":"Chao Han ,&nbsp;Shijun Xiang ,&nbsp;Renchao Zhang ,&nbsp;Gang Cen,&nbsp;Yuan Fang,&nbsp;Zhengjun Qiu,&nbsp;Chen Huang","doi":"10.1016/j.isurg.2023.02.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The aim of this study was to describe technical considerations and short-term outcomes from the first reported single-incision robotic operation for distal gastrectomy with the use of da Vinci Xi surgical system.</p></div><div><h3>Methods</h3><p>A 71-year-old patient with a body-mass index of 22.4 ​kg/m<sup>2</sup> was treated for a gastrointestinal stromal tumor(GIST) in the posterior wall of the gastric antrum by single-incision robot-assisted distal gastrectomy with the da Vinci Xi robotic system on September 17, 2022 in Shanghai General Hospital.</p></div><div><h3>Results</h3><p>The single-incision da Vinci Xi robot-assisted distal gastrectomy was successfully performed with intraperitoneal Billroth Ⅱ anastomosis. The console time among the operation was 100 ​min with 10 ​ml of intraoperative blood loss. The patient was put on a liquid diet the next day after surgery and discharged on postoperative day 4. During the postoperative period, no severe adverse events occurred. The final pathology revealed a low-risk gastrointestinal stromal tumor (GIST) with a size of 5.0 ​× ​3.5 ​× ​2.5 ​cm.</p></div><div><h3>Conclusion</h3><p>Single-incision da Vinci Xi robot-assisted distal gastrectomy was a safe and feasible surgical method for patients with gastric tumor. The study filled in the corresponding research gaps and provided a basis for subsequent research. To verify its superior operative outcomes, further clinical trials are needed.</p></div>","PeriodicalId":100683,"journal":{"name":"Intelligent Surgery","volume":"6 ","pages":"Pages 12-15"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intelligent Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666676623000029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

术中控制时间100min,术中出血量10ml。术后第2天给予流质饮食,术后第4天出院。术后无严重不良事件发生。最终病理显示为低危胃肠道间质瘤(GIST),大小为5.0 × 3.5 × 2.5 cm。本研究填补了相应的研究空白,为后续研究提供了基础。为了验证其良好的手术效果,需要进一步的临床试验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Initial experience of single-incision robotic surgery for distal gastrectomy with da Vinci Xi platform

Background

The aim of this study was to describe technical considerations and short-term outcomes from the first reported single-incision robotic operation for distal gastrectomy with the use of da Vinci Xi surgical system.

Methods

A 71-year-old patient with a body-mass index of 22.4 ​kg/m2 was treated for a gastrointestinal stromal tumor(GIST) in the posterior wall of the gastric antrum by single-incision robot-assisted distal gastrectomy with the da Vinci Xi robotic system on September 17, 2022 in Shanghai General Hospital.

Results

The single-incision da Vinci Xi robot-assisted distal gastrectomy was successfully performed with intraperitoneal Billroth Ⅱ anastomosis. The console time among the operation was 100 ​min with 10 ​ml of intraoperative blood loss. The patient was put on a liquid diet the next day after surgery and discharged on postoperative day 4. During the postoperative period, no severe adverse events occurred. The final pathology revealed a low-risk gastrointestinal stromal tumor (GIST) with a size of 5.0 ​× ​3.5 ​× ​2.5 ​cm.

Conclusion

Single-incision da Vinci Xi robot-assisted distal gastrectomy was a safe and feasible surgical method for patients with gastric tumor. The study filled in the corresponding research gaps and provided a basis for subsequent research. To verify its superior operative outcomes, further clinical trials are needed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信